Canadian firm Spartan filing for creditor protection amid inconsistencies with rapid COVID-19 test
An Ottawa-based biotech company, Spartan Bioscience Inc., is filing for creditor protection and temporarily laying off staff following concerns about the consistency of the company’s rapid COVID-19 tests.
www.ctvnews.ca
An Ottawa-based biotech company, Spartan Bioscience Inc., is filing for creditor protection and temporarily laying off staff following concerns about the consistency of the company’s rapid COVID-19 tests.
Spartan told CTV News on Tuesday that about 60 of its 90 employees and a number of students and interns would be laid off as the company deals with the issue.
The “performance-related” issues the company started seeing after the rapid test was launched last year, coupled with a lack of resources that larger biotech companies have, “has left us in a position where we have a strain on our cash,” Spartan interim Chief Executive Officer Jennifer Ross-Carriere said in an interview.
